Neither autoantibody production nor T and B cell activation was significantly affected (115), suggesting that the protective effect of MIF inhibition in SLE is dependent on the regulation of innate inflammation rather that autoimmunity. This evidence concerns the gene MIF and systemic lupus erythematosus.